Valneva Stock: 2026 Performance, Market Cap, and Vaccine Focus
Valneva (VLA.PA) shares dip 1.75% today; 52‑week low 2.03€, high 5.15€. Explore Valneva’s vaccine pipeline, market cap and recent performance.
2 minutes to read
VALNEVA SE
Valneva’s Stock Drops 1.75% – Still Offers Upside Amid Strong Vaccine Pipeline
Valneva’s stock dips yet offers a value‑edge: robust vaccine pipeline, proven licensing, and upside potential below the 200‑day average—ideal for long‑term investors.
3 minutes to read